tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RNTX Stock Latest News

Rein Therapeutics Secures Second Advance in Funding Deal
Company AnnouncementsRein Therapeutics Secures Second Advance in Funding Deal
4d ago
8K
RNTX
Rein Therapeutics files to sell 10M shares of common stock for holders
PremiumThe Fly
Rein Therapeutics files to sell 10M shares of common stock for holders
10d ago
RNTX
Home Depot reports Q2 results, SoftBank invests $2B in Intel: Morning Buzz
PremiumThe Fly
Home Depot reports Q2 results, SoftBank invests $2B in Intel: Morning Buzz
25d ago
F
AS
Palo Alto upgraded, Li Auto downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Palo Alto upgraded, Li Auto downgraded: Wall Street’s top analyst calls
25d ago
LI
TH
Rein Therapeutics Gains Approval for Phase 2 Trial
PremiumCompany Announcements
Rein Therapeutics Gains Approval for Phase 2 Trial
25d ago
8K
RNTX
Rein announces U.K. MHRA authorized to initiate Phase 2 ‘RENEW’ trial
PremiumThe FlyRein announces U.K. MHRA authorized to initiate Phase 2 ‘RENEW’ trial
25d ago
RNTX
Rein Therapeutics downgraded to Hold from Buy at Brookline
Premium
The Fly
Rein Therapeutics downgraded to Hold from Buy at Brookline
25d ago
RNTX
Rein Therapeutics Completes Promising IPF Treatment Study
Premium
Company Announcements
Rein Therapeutics Completes Promising IPF Treatment Study
1M ago
RNTX
Rein Therapeutics Secures New Financial Agreements
PremiumCompany Announcements
Rein Therapeutics Secures New Financial Agreements
2M ago
8K
RNTX
Rein Therapeutics enters agreements for up to $21M in financing
PremiumThe Fly
Rein Therapeutics enters agreements for up to $21M in financing
2M ago
RNTX
Rein Therapeutics Elects New Director at Annual Meeting
PremiumCompany Announcements
Rein Therapeutics Elects New Director at Annual Meeting
2M ago
8K
RNTX
Rein Therapeutics Amends By-Laws for Quorum Requirement
PremiumCompany Announcements
Rein Therapeutics Amends By-Laws for Quorum Requirement
2M ago
8K
RNTX
Rein Therapeutics Adjourns 2025 Annual Meeting
PremiumCompany AnnouncementsRein Therapeutics Adjourns 2025 Annual Meeting
3M ago
8K
RNTX
Rein Therapeutics Pauses U.S. Enrollment for RENEW Trial
Premium
Company Announcements
Rein Therapeutics Pauses U.S. Enrollment for RENEW Trial
3M ago
8K
RNTX
Rein Therapeutics says first patient dosed in Renew Phase 2 trial of LTI-03
Premium
The Fly
Rein Therapeutics says first patient dosed in Renew Phase 2 trial of LTI-03
4M ago
IQV
RNTX
Rein Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Rein Therapeutics Reports Q1 2025 Financial Results
4M ago
RNTX
Rein Therapeutics files $150M mixed securities shelf
PremiumThe Fly
Rein Therapeutics files $150M mixed securities shelf
4M ago
RNTX
Rein begins RENEW Phase 2 trial of LTI-03
PremiumThe Fly
Rein begins RENEW Phase 2 trial of LTI-03
4M ago
RNTX
Rein Therapeutics awarded to patents related to LTI-03
PremiumThe Fly
Rein Therapeutics awarded to patents related to LTI-03
5M ago
RNTX
Rein Therapeutics’ LTI-2355 peptide shows therapuetic potential in study
PremiumThe FlyRein Therapeutics’ LTI-2355 peptide shows therapuetic potential in study
5M ago
RNTX
Rein Therapeutics reports Q4 EPS ($1.89) vs. ($1.54) last year
Premium
The Fly
Rein Therapeutics reports Q4 EPS ($1.89) vs. ($1.54) last year
5M ago
RNTX
Rein Therapeutics Delays Annual Report Filing
Premium
Company Announcements
Rein Therapeutics Delays Annual Report Filing
6M ago
RNTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >